Since the founding in 1976 of its Belgian Centre for Pharmacovigilance (CBPH), the Federal Agency for Medicines and Health Products (FAMHP), which is the competent authority regarding medicines, received more than 50,000 notifications, mainly serious adverse effects, from health care providers and the pharmaceutical industry (legal requirement since 1995). On its own initiative, Test-Achats created in 2006 a contact point for patients to report adverse reactions and other problems concerning medicines.
In 2007 the FAMHP and Test-Achats concluded a collaboration agreement for the exchange of information on adverse events reported by the patients.
See other langaues (French or Dutch).